申请人:Pfizer Inc.
公开号:US20140128363A1
公开(公告)日:2014-05-08
The present invention is directed to a new class of hydroxamic acid derivatives, their use as LpxC inhibitors, and more specifically their use to treat bacterial infections.
本发明涉及一种新的羟肟酸衍生物类,其用作LpxC抑制剂,更具体地用于治疗细菌感染。